Evidence map›Paper›PMID 26439639›Full record

ArticleNature communications2015

Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.

Hélène O B Gautier, Kimberley A Evans, Katrin Volbracht, Rachel James, Sergey Sitnikov, Iben Lundgaard, Fiona James, Cristina Lao-Peregrin, Richard Reynolds, Robin J M Franklin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 293 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. NG2 Glia and Cellular Crosstalk in Health and Disease: Focus on Spinal Cord Injury.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hélène O B GautierWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Kimberley A EvansWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Katrin VolbrachtWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Rachel JamesFaculty of Medicine, Division of Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
Sergey SitnikovWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Iben LundgaardWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Fiona JamesWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Cristina Lao-PeregrinWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Richard ReynoldsFaculty of Medicine, Division of Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
Robin J M FranklinWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, UK.
Ragnhildur T KáradóttirWellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Medical Research Council · GBUniversity of Cambridge · GBImperial College London · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council 1233560Medical Research Council G0701476Multiple Sclerosis Society 747Wellcome Trust 091543/Z/10/ZWellcome Trust 97922
6 · The paper itself

Abstract

Myelin regeneration can occur spontaneously in demyelinating diseases such as multiple sclerosis (MS). However, the underlying mechanisms and causes of its frequent failure remain incompletely understood. Here we show, using an in-vivo remyelination model, that demyelinated axons are electrically active and generate de novo synapses with recruited oligodendrocyte progenitor cells (OPCs), which, early after lesion induction, sense neuronal activity by expressing AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)/kainate receptors. Blocking neuronal activity, axonal vesicular release or AMPA receptors in demyelinated lesions results in reduced remyelination. In the absence of neuronal activity there is a ∼6-fold increase in OPC number within the lesions and a reduced proportion of differentiated oligodendrocytes. These findings reveal that neuronal activity and release of glutamate instruct OPCs to differentiate into new myelinating oligodendrocytes that recover lost function. Co-localization of OPCs with the presynaptic protein VGluT2 in MS lesions implies that this mechanism may provide novel targets to therapeutically enhance remyelination.

Indexed as

Action PotentialsAdultAnimalsAxonsBrainFemaleGlutamic AcidHumansImmunohistochemistryKainic Acid ReceptorsMaleMicroscopy, ElectronMiddle AgedMultiple SclerosisMyelin SheathNeuronsGlutamic AcidKainic Acid ReceptorsReceptors, AMPASLC17A6 protein, humanVesicular Glutamate Transport Protein 2

Identifiers

PMID26439639
PMCPMC4600759
OpenAlexW1446040360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.